-
EP3782625
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3782625
| EP3782625 - AGENT FOR IMPROVING CYTOKINE RELEASE SYNDROME [Right-click to bookmark this link] | |||
| Former [2021/08] | AGENT FOR IMPROVING CYTOKINE RELEASE SYNDROME, ETC | ||
| [2024/21] | Status | The patent has been granted Status updated on 19.09.2024 Database last updated on 30.10.2024 | |
| Former | Grant of patent is intended Status updated on 12.05.2024 | ||
| Former | Examination is in progress Status updated on 18.03.2022 | ||
| Former | Request for examination was made Status updated on 22.01.2021 | ||
| Former | The international publication has been made Status updated on 06.06.2020 | Most recent event Tooltip | 19.09.2024 | (Expected) grant | published on 23.10.2024 [2024/43] | Applicant(s) | For all designated states TORII PHARMACEUTICAL CO., LTD. 4-1, Nihonbashi-Honcho, 3-chome Chou-ku Tokyo 103-8439 / JP | [2024/41] |
| Former [2021/08] | For all designated states TORII PHARMACEUTICAL CO., LTD. 4-1, Nihonbashi Honcho 3-chome Chuo-ku Tokyo 103-8439 / JP | Inventor(s) | 01 /
WATANABE Yoshihiro c/o TORII PHARMACEUTICAL CO., LTD., 4-1, Nihonbashi-Honcho 3-chome, Chuo-ku Tokyo 103-8439 / JP | 02 /
TAHARA Yoshio c/o TORII PHARMACEUTICAL CO., LTD., 4-1, Nihonbashi-Honcho 3-chome, Chuo-ku Tokyo 103-8439 / JP | 03 /
SUZUKI Keisuke c/o TORII PHARMACEUTICAL CO., LTD., 4-1, Nihonbashi-Honcho 3-chome, Chuo-ku Tokyo 103-8439 / JP | 04 /
MIMURA Takayuki c/o TORII PHARMACEUTICAL CO., LTD., 4-1, Nihonbashi-Honcho 3-chome, Chuo-ku Tokyo 103-8439 / JP | 05 /
OHMAE Saori c/o TORII PHARMACEUTICAL CO., LTD., 4-1, Nihonbashi-Honcho 3-chome, Chuo-ku Tokyo 103-8439 / JP | [2021/08] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [2024/43] |
| Former [2021/08] | J A Kemp LLP 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 19889164.0 | 29.11.2019 | [2021/08] | WO2019JP46689 | Priority number, date | JP20180223377 | 29.11.2018 Original published format: JP 2018223377 | JP20190165013 | 11.09.2019 Original published format: JP 2019165013 | [2021/08] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020111212 | Date: | 04.06.2020 | Language: | JA | [2020/23] | Type: | A1 Application with search report | No.: | EP3782625 | Date: | 24.02.2021 | Language: | EN | [2021/08] | Type: | B1 Patent specification | No.: | EP3782625 | Date: | 23.10.2024 | Language: | EN | [2024/43] | Search report(s) | International search report - published on: | JP | 04.06.2020 | (Supplementary) European search report - dispatched on: | EP | 11.06.2021 | Classification | IPC: | A61K31/495, A61P29/00, A61P43/00, A61P37/00 | [2021/28] | CPC: |
A61P37/00 (EP,KR);
A61K31/495 (EP,KR,US);
A61P29/00 (EP,KR);
A61P37/06 (US);
A61P43/00 (EP,KR)
|
| Former IPC [2021/08] | A61K31/495, A61P29/00, A61P43/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/08] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | MITTEL ZUR VERBESSERUNG DES ZYTOKINFREISETZUNGSSYNDROMS | [2024/21] | English: | AGENT FOR IMPROVING CYTOKINE RELEASE SYNDROME | [2024/21] | French: | AGENT POUR AMÉLIORER LE SYNDROME DE LIBÉRATION DE CYTOKINES | [2024/21] |
| Former [2021/08] | MITTEL ZUR VERBESSERUNG DES ZYTOKINFREISETZUNGSSYNDROMS USW. | ||
| Former [2021/08] | AGENT FOR IMPROVING CYTOKINE RELEASE SYNDROME, ETC | ||
| Former [2021/08] | AGENT POUR AMÉLIORER LE SYNDROME DE LIBÉRATION DE CYTOKINES, ETC | Entry into regional phase | 03.11.2020 | Translation filed | 03.11.2020 | National basic fee paid | 03.11.2020 | Search fee paid | 03.11.2020 | Designation fee(s) paid | 03.11.2020 | Examination fee paid | Examination procedure | 03.11.2020 | Examination requested [2021/08] | 31.12.2021 | Amendment by applicant (claims and/or description) | 18.03.2022 | Despatch of a communication from the examining division (Time limit: M06) | 28.09.2022 | Reply to a communication from the examining division | 02.06.2023 | Invitation to indicate the basis for amendments (Time limit: M01) | 11.07.2023 | Reply to an invitation to indicate the basis for amendments | 13.05.2024 | Communication of intention to grant the patent | 11.09.2024 | Fee for grant paid | 11.09.2024 | Fee for publishing/printing paid | 11.09.2024 | Receipt of the translation of the claim(s) | Fees paid | Renewal fee | 30.11.2021 | Renewal fee patent year 03 | 26.10.2022 | Renewal fee patent year 04 | 11.10.2023 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]US2009131329 (MILLER EDMUND JOHN [US], et al) | International search | [Y]WO9708133 (JAPAN TOBACCO INC [JP], et al); | by applicant | WO9708133 |